Existing Aarti Industries facility, not the proposed plant. Photo: Aarti Industries.
Aarti Industries has signed a dedicated manufacturing and supply agreement lasting more than 10 years with an unnamed global specialty chemical company.
The agreement, announced on 13 October 2026, has estimated cumulative revenue potential of approximately ₹1,500 crore over its term, described by Aarti as about US$150 million. It establishes a new customer relationship and will serve the customer’s requirements in India.
Aarti will establish, commission and operate an Indian facility producing a specialty chemical for high-performance applications using the customer’s proprietary technology.
Capital expenditure is expected to remain below US$25 million under a structured financing arrangement. Commercial operations are targeted for FY2028–29, subject to approvals.
Managing Director and CEO Suyog Kotecha said: “This agreement brings a new global customer into AIL’s portfolio”.
The product, plant capacity, location and detailed financing terms were not disclosed.
Market Research Outlook’s View
The agreement gives Aarti a defined customer for a dedicated manufacturing asset. Its returns will depend on volume commitments, pricing and capital responsibilities, which remain undisclosed. The contract supports a specific localization opportunity; it does not establish a broader recovery in specialty chemical demand.
Related coverage: India Chemical Projects Tracker.
